Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-05
2008-10-21
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S397000, C514S469000
Reexamination Certificate
active
07439374
ABSTRACT:
The present invention provides compounds of Formula 1,wherein the variables Ar, A1, A2, A3, A4, R5, R6, R7, V, W, X, and Y are defined herein.Certain compounds of Formula 1 described herein possess potent antiviral activity. The invention also provides compounds of Formula 1 that are potent and/or selective inhibitors of Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more compounds of Formula 1, or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents. The invention further comprises methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula 1 effective to reduce signs or symptoms of the disease. These infectious diseases include viral infections, particularly HCV infections. The invention is particularly includes methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease.Methods of treatment include administering a compound of Formula 1 as a single active agent or administering a compound of Formula 1 in combination with on or more other therapeutic agent.
REFERENCES:
patent: 6174905 (2001-01-01), Suzuki et al.
patent: 6399657 (2002-06-01), Bräunlich et al.
patent: 6677372 (2004-01-01), Bräunlich et al.
patent: 2003/0109578 (2003-06-01), Bräunlich et al.
patent: 0 526 009 (1993-02-01), None
patent: 0 806 205 (1997-11-01), None
patent: 1 408 198 (1975-10-01), None
patent: WO 2004/041201 (2004-05-01), None
patent: WO 2004/046095 (2004-06-01), None
patent: WO 2005/007601 (2005-01-01), None
P. Reynaud et al., “Preparation de quelques p-alcoxy benzoyl-1 p-alcoxyphenyl-3 thiourees: leur activite <<in vitro>> et <<in vivo>> sur la souche H37RV du bacille tuberculeux” Chimie Therapeutique, (7) 421-424 (1966) (Translation included).
Database Caplus ′Online!, Chemical Abstracts Service, Columbus, Ohio, US; (1989), Retrieved from STN Database accession No. 1989: 614340 abstract & S. A. Zotova et al., : “Synthesis and antiviral activity of 5-methoxybenzofuran derivatives” Khimiko-farmatsevticheskii Zhurnal, vol. 23, No. 2, 1989, pp. 191-195.
Chen Dawei
Deshpande Milind
Li Shouming
Phadke Avinash
Thurkauf Andrew
Achillion Pharmaceuticals, Inc.
Cantor & Colburn LLP
Chandrakumar Nizal S
Seaman D. Margaret
LandOfFree
Azabenzofuran substituted thioureas; inhibitors of viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabenzofuran substituted thioureas; inhibitors of viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabenzofuran substituted thioureas; inhibitors of viral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004423